|
1
|
Raj PA and Dentino AR: Current status of
defensins and their role in innate and adaptive immunity. FEMS
Microbiol Lett. 206:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ganz T: Defensins: antimicrobial peptides
of innate immunity. Nat Rev Immunol. 3:710–720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang D, Biragyn A, Hoover DM, Lubkowski J
and Oppenheim JJ: Multiple roles of antimicrobial defensins,
cathelicidins, and eosinophil-derived neurotoxin in host defense.
Annu Rev Immunol. 22:181–215. 2004. View Article : Google Scholar
|
|
4
|
Schutte BC, Mitros JP, Bartlett JA, et al:
Discovery of five conserved beta-defensin gene clusters using a
computational search strategy. Proc Natl Acad Sci USA.
99:2129–2133. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jia HP, Schutte BC, Schudy A, et al:
Discovery of new human beta-defensins using a genomics-based
approach. Gene. 263:211–218. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sorensen OE, Thapa DR, Rosenthal A, Liu L,
Roberts AA and Ganz T: Differential regulation of beta-defensin
expression in human skin by microbial stimuli. J Immunol.
174:4870–4879. 2005. View Article : Google Scholar
|
|
7
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Z, Hoover DM, Yang D, et al:
Engineering disulfide bridges to dissect antimicrobial and
chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci
USA. 100:8880–8885. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shestakova T, Zhuravel E, Bolgova L,
Alekseenko O, Soldatkina M and Pogrebnoy P: Expression of human
beta-defensins-1, 2 and 4 mRNA in human lung tumor tissue: a pilot
study. Exp Oncol. 30:153–156. 2008.PubMed/NCBI
|
|
10
|
Shestakova T, Zhuravel E, Bolgova L, et
al: Immunohistochemical analysis of beta-defensin-2 expression in
human lung tumors. Exp Oncol. 32:273–276. 2010.PubMed/NCBI
|
|
11
|
Arimura Y, Ashitani J, Yanagi S, et al:
Elevated serum beta-defensins concentrations in patients with lung
cancer. Anticancer Res. 24:4051–4057. 2004.PubMed/NCBI
|
|
12
|
Markeeva N, Lisovskiy I, Lyzogubov V, et
al: Expression of beta-defensin-2 in human gastric tumors: a pilot
study. Exp Oncol. 27:130–135. 2005.PubMed/NCBI
|
|
13
|
Markeeva N, Lysovskiy I, Zhuravel E, et
al: Involvement of human beta-defensin-2 in proliferation of
transformed cells of human cervix. Exp Oncol. 27:308–313.
2005.PubMed/NCBI
|
|
14
|
Mburu YK, Abe K, Ferris LK, Sarkar SN and
Ferris RL: Human beta-defensin 3 promotes NF-kappaB-mediated CCR7
expression and anti-apoptotic signals in squamous cell carcinoma of
the head and neck. Carcinogenesis. 32:168–174. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Melle C, Ernst G, Schimmel B, et al:
Discovery and identification of alpha-defensins as low abundant,
tumor-derived serum markers in colorectal cancer. Gastroenterology.
129:66–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Albrethsen J, Bogebo R, Gammeltoft S,
Olsen J, Winther B and Raskov H: Upregulated expression of human
neutrophil peptides 1, 2 and 3 (HNP 1–3) in colon cancer serum and
tumours: a biomarker study. BMC Cancer. 5:82005.
|
|
17
|
Albrethsen J, Moller CH, Olsen J, Raskov H
and Gammeltoft S: Human neutrophil peptides 1, 2 and 3 are
biochemical markers for metastatic colorectal cancer. Eur J Cancer.
42:3057–3064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang K, Wang JH, Baskaran H, Wang R and
Jurevic R: Effect of human beta-defensin-3 on head and neck cancer
cell migration using micro-fabricated cell islands. Head Neck
Oncol. 4:412012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kawsar HI, Weinberg A, Hirsch SA, et al:
Overexpression of human beta-defensin-3 in oral dysplasia:
potential role in macrophage trafficking. Oral Oncol. 45:696–702.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Winter J, Pantelis A, Reich R, et al:
Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral
squamous cell carcinoma cell proliferation. Cancer Invest.
29:196–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harder J, Bartels J, Christophers E and
Schroder JM: Isolation and characterization of human
beta-defensin-3, a novel human inducible peptide antibiotic. J Biol
Chem. 276:5707–5713. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawauchi K, Yagihashi A, Tsuji N, et al:
Human beta-defensin-3 induction in H. pylori-infected
gastric mucosal tissues. World J Gastroenterol. 12:5793–5797.
2006.PubMed/NCBI
|
|
23
|
Fahlgren A, Hammarstrom S, Danielsson A
and Hammarstrom ML: beta-Defensin-3 and -4 in intestinal epithelial
cells display increased mRNA expression in ulcerative colitis. Clin
Exp Immunol. 137:379–385. 2004. View Article : Google Scholar
|
|
24
|
Donald CD, Sun CQ, Lim SD, et al:
Cancer-specific loss of beta-defensin 1 in renal and prostatic
carcinomas. Lab Invest. 83:501–505. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Young AN, de Oliveira Salles PG, Lim SD,
et al: Beta defensin-1, parvalbumin, and vimentin: a panel of
diagnostic immunohistochemical markers for renal tumors derived
from gene expression profiling studies using cDNA microarrays. Am J
Surg Pathol. 27:199–205. 2003. View Article : Google Scholar
|
|
26
|
Bullard RS, Gibson W, Bose SK, et al:
Functional analysis of the host defense peptide Human Beta
Defensin-1: new insight into its potential role in cancer. Mol
Immunol. 45:839–848. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joly S, Compton LM, Pujol C, Kurago ZB and
Guthmiller JM: Loss of human beta-defensin 1, 2, and 3 expression
in oral squamous cell carcinoma. Oral Microbiol Immunol.
24:353–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoshimoto T, Yamaai T, Mizukawa N, et al:
Different expression patterns of beta-defensins in human squamous
cell carcinomas. Anticancer Res. 23:4629–4633. 2003.PubMed/NCBI
|
|
29
|
Shuyi Y, Feng W, Jing T, et al: Human
beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth
factor receptor (EGFR) signaling pathways to enhance lymphatic
invasion of oral squamous cell carcinoma. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 112:616–625. 2011. View Article : Google Scholar
|
|
30
|
Xu N, Wang YS, Pan WB, et al: Human
alpha-defensin-1 inhibits growth of human lung adenocarcinoma
xenograft in nude mice. Mol Cancer Ther. 7:1588–1597. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toh Y, Oki E, Oda S, et al: Overexpression
of the MTA1 gene in gastrointestinal carcinomas: correlation with
invasion and metastasis. Int J Cancer. 74:459–463. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin MD, Fischbach K, Osborne CK, Mohsin
SK, Allred DC and O’Connell P: Loss of heterozygosity events
impeding breast cancer metastasis contain the MTA1 gene. Cancer
Res. 61:3578–3580. 2001.PubMed/NCBI
|
|
33
|
Hamatsu T, Rikimaru T, Yamashita Y, et al:
The role of MTA1 gene expression in human hepatocellular carcinoma.
Oncol Rep. 10:599–604. 2003.PubMed/NCBI
|
|
34
|
Sasaki H, Moriyama S, Nakashima Y, et al:
Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer.
35:149–154. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Ng HH, Erdjument-Bromage H,
Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits
reveals a histone deacetylase core complex and a connection with
DNA methylation. Genes Dev. 13:1924–1935. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Toh Y and Nicolson GL: The role of the MTA
family and their encoded proteins in human cancers: molecular
functions and clinical implications. Clin Exp Metastasis.
26:215–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ji Y, Zhang P, Lu Y and Ma D: Expression
of MTA2 gene in ovarian epithelial cancer and its clinical
implication. J Huazhong Univ Sci Technolog Med Sci. 26:359–362.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee H, Ryu SH, Hong SS, et al:
Overexpression of metastasis-associated protein 2 is associated
with hepatocellular carcinoma size and differentiation. J
Gastroenterol Hepatol. 24:1445–1450. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu SL, Han Y, Zhang Y, et al: Expression
of metastasis-associated protein 2 (MTA2) might predict
proliferation in non-small cell lung cancer. Target Oncol.
7:135–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Covington KR, Brusco L, Barone I, et al:
Metastasis tumor-associated protein 2 enhances metastatic behavior
and is associated with poor outcomes in estrogen receptor-negative
breast cancer. Breast Cancer Res Treat. 141:375–384. 2013.
View Article : Google Scholar
|
|
41
|
Zhou C, Ji J, Cai Q, et al: MTA2 promotes
gastric cancer cells invasion and is transcriptionally regulated by
Sp1. Mol Cancer. 12:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cui Y, Niu A, Pestell R, et al:
Metastasis-associated protein 2 is a repressor of estrogen receptor
alpha whose overexpression leads to estrogen-independent growth of
human breast cancer cells. Mol Endocrinol. 20:2020–2035. 2006.
View Article : Google Scholar
|
|
43
|
Luo J, Su F, Chen D, Shiloh A and Gu W:
Deacetylation of p53 modulates its effect on cell growth and
apoptosis. Nature. 408:377–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
